Future chemotherapy and radiotherapy options in head and neck cancer

Expert Review of Anticancer Therapy
Marco Merlano, Valentina Polla Mattiot

Abstract

Chemoradiation is a standard approach to advanced unresectable head and neck cancer, although the optimum combination regimen remains controversial. However, in the past few years, chemoradiation has been successfully extended from the treatment of unresectable disease to the postsurgical therapy of high-risk patients and its value as an organ preservation procedure is under evaluation. More recently, molecular-targeted therapies have emerged, which interfere with mechanisms of chemo- and radioresistance, and preliminary data are promising. Their use in the combined treatment of head and neck cancer will hopefully further improve the value of chemoradiation in the clinical setting.

References

Apr 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M MerlanoD Scarpati
Dec 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G P BrowmanM N Levine
Feb 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S G TaylorJ C Hutchinson
Apr 29, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M Al-SarrafJ F Ensley
Apr 29, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T G WendtA Schalhorn
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M S KiesE E Vokes
Sep 24, 1999·Hematology/oncology Clinics of North America·B G Haffty
Mar 29, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B JeremicL Tadic
Feb 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A EisbruchT S Lawrence
Feb 15, 2001·International Journal of Radiation Oncology, Biology, Physics·P M Harari, S M Huang
Jan 5, 2002·The New England Journal of Medicine·A ForastiereD Sidransky
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V Craig Jordan, Monica Morrow
Jan 23, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C Hennequin, V Favaudon
Aug 15, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C MonneratE Raymond
Sep 28, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mitchell MachtayUNKNOWN Penn Cancer Center Clinical Trials Group
Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David J AdelsteinArlene A Forastiere
Aug 12, 2003·International Journal of Radiation Oncology, Biology, Physics·Ke LiangZhen Fan
Aug 21, 2003·Cancer Treatment Reviews·Marco Merlano, Giuseppe Marchetti
Aug 23, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M BenassoR Rosso
Feb 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Judith S Ochs
Mar 23, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M BenassoR Rosso
May 7, 2004·The New England Journal of Medicine·Jay S CooperUNKNOWN Radiation Therapy Oncology Group 9501/Intergroup
May 7, 2004·The New England Journal of Medicine·Jacques BernierUNKNOWN European Organization for Research and Treatment of Cancer Trial 22931
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David H JohnsonFairooz Kabbinavar
Nov 10, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pia HugueninChristoph Glanzmann
Dec 23, 2004·Endocrine-related Cancer·P M Harari
Aug 10, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Marco MerlanoMarco Cipolat
Aug 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shaji KumarThomas E Witzig
Jan 18, 2006·International Journal of Radiation Oncology, Biology, Physics·Abby Rosenberg, Susan Knox

❮ Previous
Next ❯

Citations

Nov 26, 2015·Indian Journal of Pharmacology·Arunava Kali

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.